Updates for Migraine Management
Registration

By clicking the continue button above, I certify that I have read the CME information below. 

A CME-certified Symposium for Residents and Fellows

Saturday, November 3, 2018 
Registration: 8:30 AM - 9:00 AM
CME Program 9:00 AM - 10:00 AM

Marriott Marquis San Diego Marina
San Diego, CA
Marriott Grand Ballroom 1-4

PROGRAM OVERVIEW

Based solely on clinical evaluation, the diagnosis of migraine can be challenging for clinicians. Its management typically requires lifestyle and trigger management, along with acute, preventive, or combination treatments. Recent migraine research has focused on the role of the calcitonin gene-related peptide (CGRP), which is released in significant amounts during an acute attack and is chronically elevated in patients with chronic migraine. 

The development of novel medications targeting the CGRP pathway could offer an effective option for patients with acute and chronic migraine. Residents and fellows will play an increasingly important role in identifying patients with migraine headache and ensuring that they are properly diagnosed and appropriately treated. The CME activity, Updates for Migraine Management, will provide these clinicians with the latest evidence-based strategies and emerging therapies for migraine management. 

AGENDA
Welcome, Introductions, and Pre-Survey 
Migraine: The Scope of the Problem
Pathophysiology of Migraine
Current and Emerging Agents 
Case Consult/Q&A Session

CASE CONSULT
If you have a challenging migraine case you would like to hear discussed by the faculty at this program, email the information to migrainechampion@rockpointe.com no later than 72 hours prior to the program start, in order to receive expert opinions and recommendations on management choices. One of the cases submitted will be presented as part of the program. All case information will be kept confidential and presented anonymously. 

TARGET AUDIENCE
This activity is intended for residents, fellows, general practitioners, and allied healthcare providers who treat patients at risk for or who have migraine. 

EDUCATIONAL OBJECTIVES
At the conclusion of this activity, participants should be able to: 

  • Examine the epidemiology, differential diagnosis, and impact of migraine within the primary-care patient population
  • Describe the pathophysiology of migraine, including the role of calcitonin gene-related peptide (CGRP)
  • Delineate current standards of pharmacologic and nonpharmacologic management for the preventive and acute management of migraine
  • Assess clinical safety and efficacy data for emerging therapeutic agents for the prevention and treatment of migraines

PROGRAM FACULTY AND STEERING COMMITTEE 
 Jack Schim, MD
 Co-Director, The Headache Center of Southern California
 
Carlsbad, CA

 

 

 

 Christopher Damiano, DO, MPH
 PGY-3 Internal Medicine
 Lankenau Medical Center
 Wynnewood, PA 

 

 

STEERING COMMITTEE
M. Susan Burke, MD, FACP 
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, PA

Matthew Delmonico, DO
Chief Resident, Internal Medicine Program
Lankenau Medical Center
Wynnewood, PA

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians. 

DESIGNATION STATMENT
The Potomac Center for Medical Education designates this live activity for the maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

DISCLOSURE STATEMENT 
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. 

All persons in a position to control content of a continuing medical education program provided by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards of Commercial Support in advance of delivery of the activity to learners. The content of this activity was vetted by an external reviewer to assure objectivity and that the activity is free of commercial bias. 

FDA DISCLOSURE
The contents of some CME activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses. 

METHOD OF PARTICIPATION
To complete the activity and receive credit, the participant must attend the program and complete the evaluation form. A CME certificate will be emailed within 2 weeks upon submission of a completed evaluation form. 

SPECIAL SERVICES
Event staff will be glad to assist you with any special needs (e.g. physical, dietary, etc.). Please email specialservices@rockpointe-pcme.com at least 5 days prior to the program. 

Jointly provided by the Potomac Center for Medical Education and Rockpointe. 

             

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com